<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03727425</url>
  </required_header>
  <id_info>
    <org_study_id>18-BR-0001</org_study_id>
    <nct_id>NCT03727425</nct_id>
  </id_info>
  <brief_title>Robotic Bronchoscopy for Peripheral Pulmonary Lesions</brief_title>
  <official_title>Robotic Bronchoscopy for Peripheral Pulmonary Lesions: A Multicenter Pilot and Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Auris Health, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Auris Health, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the feasibility of performing robotic navigation of peripheral airways in&#xD;
      human subjects for the purpose of biopsying peripheral lung lesions will be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Successful biopsy of peripheral pulmonary lesions remains a challenge due to a number of&#xD;
      factors, one of which may be the ability to gain access to peripheral lesions due to the size&#xD;
      and maneuverability of conventional bronchoscopes. In this study, the investigators will&#xD;
      evaluate the feasibility of a new technique using a robotic endoscope with the Monarch&#xD;
      navigational platform to both access and biopsy peripheral pulmonary lesions. The Monarch&#xD;
      platform is a &quot;robotic&quot; assisted or electromechanical, software driven endoscopy system&#xD;
      designed to be used by qualified physicians to provide bronchoscopic visualization of and&#xD;
      access to patient airways for diagnostic and therapeutic procedures.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">September 12, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Device or Procedure Related Adverse Events</measure>
    <time_frame>24-84 hours post-procedure</time_frame>
    <description>Computed as the number of patients with device or procedure related adverse events divided by number of patients who underwent the robotic bronchoscopy procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Successful Navigation to Targeted Peripheral Pulmonary Lesions</measure>
    <time_frame>During the procedure, approximately 1 hour</time_frame>
    <description>Successful navigation is confirmed using radial probe endobronchial ultrasound (R-EBUS). the R-EBUS will be inserted into the working channel of the endoscope and advanced beyond the tip of the inner scope as the inner scope is advanced into the lung periphery towards the targeted lesion. As the endoscope is guided towards the targeted lesion, R-EBUS will confirm successful lesion localization prior to biopsies being performed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Complications Unrelated to Device</measure>
    <time_frame>24-84 hours post-procedure</time_frame>
    <description>Computed as the number of patients with events unrelated to device or procedure divided by number of patients who underwent the robotic bronchoscopy procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to R-EBUS Confirmation (Lesion Localization)</measure>
    <time_frame>During the procedure, approximately 1 hour</time_frame>
    <description>Defined by the time the robotic bronchoscope is inserted into the oropharynx until the localization of the targeted lesion is confirmed by REBUS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Procedure Time</measure>
    <time_frame>During the procedure</time_frame>
    <description>Defined by the time the robotic bronchoscope is inserted into the oropharynx until the time a biopsy tool is removed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic Yield</measure>
    <time_frame>Data was collected (as part of standard of care) through 1-year for calculation of diagnostic yield.</time_frame>
    <description>Determined from the results of the bronchoscopy.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Lung; Node</condition>
  <arm_group>
    <arm_group_label>Robotic assisted bronchoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Robotic assisted bronchoscopy procedures will be performed using the Monarch platform.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Robotic assisted bronchoscopy</intervention_name>
    <description>Robotic assisted bronchoscopy of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions.</description>
    <arm_group_label>Robotic assisted bronchoscopy</arm_group_label>
    <other_name>Monarch platform</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Capable and willing to give informed consent&#xD;
&#xD;
          2. Acceptable candidate for an elective, non-emergent bronchoscopic procedure&#xD;
&#xD;
          3. Solid peripheral lung lesions suspected of malignancy, between 1-5cm in size&#xD;
             identified on thin slice CT scan within 14 days of the intended bronchoscopy procedure&#xD;
&#xD;
          4. Lack bleeding disorders&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Medical contraindication to bronchoscopy&#xD;
&#xD;
          2. Patients with a subsolid nodule and/or ground-glass opacity lesions on pre-procedure&#xD;
             chest CT&#xD;
&#xD;
          3. Patients with endobronchial involvement seen on chest CT&#xD;
&#xD;
          4. Lack fitness to undergo flexible bronchoscopy as determined by the bronchoscopist&#xD;
             prior to procedure&#xD;
&#xD;
          5. Participation in any other investigational clinical trial (device or medication) 30&#xD;
             days before and throughout the duration of the study&#xD;
&#xD;
          6. Uncontrolled or irreversible coagulopathy&#xD;
&#xD;
          7. Female subjects who are pregnant or nursing or those of child-bearing potential&#xD;
             refusing a pregnancy test&#xD;
&#xD;
          8. Have significant mediastinal lymphadenopathy on chest CT scan and/or PET CT&#xD;
             abnormalities suggestive of advanced stage lung cancer with mediastinal lymph node&#xD;
             involvement&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Chen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gerard A Silvestri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas R Gildea, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amit K Mahajan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Innova Fairfax Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael J Simoff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henry Ford Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Innova Fairfax Hospital</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 24, 2018</study_first_submitted>
  <study_first_submitted_qc>October 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2018</study_first_posted>
  <results_first_submitted>September 11, 2020</results_first_submitted>
  <results_first_submitted_qc>November 18, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 14, 2020</results_first_posted>
  <last_update_submitted>November 18, 2020</last_update_submitted>
  <last_update_submitted_qc>November 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bronchoscopy</keyword>
  <keyword>Robotic bronchoscopy</keyword>
  <keyword>Lung cancer</keyword>
  <keyword>Peripheral lesions</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 20, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/25/NCT03727425/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Robotic Assisted Bronchoscopy</title>
          <description>Robotic assisted bronchoscopy procedures will be performed using the Monarch platform.&#xD;
Robotic assisted bronchoscopy: Robotic assisted bronchoscopy of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Robotic Assisted Bronchoscopy</title>
          <description>Robotic assisted bronchoscopy procedures will be performed using the Monarch platform.&#xD;
Robotic assisted bronchoscopy: Robotic assisted bronchoscopy of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="55"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.1" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Ethnicity</title>
              <category_list>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Device or Procedure Related Adverse Events</title>
        <description>Computed as the number of patients with device or procedure related adverse events divided by number of patients who underwent the robotic bronchoscopy procedure.</description>
        <time_frame>24-84 hours post-procedure</time_frame>
        <population>54 patients underwent the robotic bronchoscopy procedure</population>
        <group_list>
          <group group_id="O1">
            <title>Robotic Assisted Bronchoscopy</title>
            <description>Robotic assisted bronchoscopy procedures will be performed using the Monarch platform.&#xD;
Robotic assisted bronchoscopy: Robotic assisted bronchoscopy of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Device or Procedure Related Adverse Events</title>
          <description>Computed as the number of patients with device or procedure related adverse events divided by number of patients who underwent the robotic bronchoscopy procedure.</description>
          <population>54 patients underwent the robotic bronchoscopy procedure</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Successful Navigation to Targeted Peripheral Pulmonary Lesions</title>
        <description>Successful navigation is confirmed using radial probe endobronchial ultrasound (R-EBUS). the R-EBUS will be inserted into the working channel of the endoscope and advanced beyond the tip of the inner scope as the inner scope is advanced into the lung periphery towards the targeted lesion. As the endoscope is guided towards the targeted lesion, R-EBUS will confirm successful lesion localization prior to biopsies being performed.</description>
        <time_frame>During the procedure, approximately 1 hour</time_frame>
        <population>Radial probe endobronchial ultrasound was available in 53/54 cases.</population>
        <group_list>
          <group group_id="O1">
            <title>Robotic Assisted Bronchoscopy</title>
            <description>Robotic assisted bronchoscopy procedures will be performed using the Monarch platform.&#xD;
Robotic assisted bronchoscopy: Robotic assisted bronchoscopy of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions.</description>
          </group>
        </group_list>
        <measure>
          <title>Successful Navigation to Targeted Peripheral Pulmonary Lesions</title>
          <description>Successful navigation is confirmed using radial probe endobronchial ultrasound (R-EBUS). the R-EBUS will be inserted into the working channel of the endoscope and advanced beyond the tip of the inner scope as the inner scope is advanced into the lung periphery towards the targeted lesion. As the endoscope is guided towards the targeted lesion, R-EBUS will confirm successful lesion localization prior to biopsies being performed.</description>
          <population>Radial probe endobronchial ultrasound was available in 53/54 cases.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Complications Unrelated to Device</title>
        <description>Computed as the number of patients with events unrelated to device or procedure divided by number of patients who underwent the robotic bronchoscopy procedure.</description>
        <time_frame>24-84 hours post-procedure</time_frame>
        <population>54 patients underwent the robotic bronchoscopy procedure</population>
        <group_list>
          <group group_id="O1">
            <title>Robotic Assisted Bronchoscopy</title>
            <description>Robotic assisted bronchoscopy procedures will be performed using the Monarch platform.&#xD;
Robotic assisted bronchoscopy: Robotic assisted bronchoscopy of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Complications Unrelated to Device</title>
          <description>Computed as the number of patients with events unrelated to device or procedure divided by number of patients who underwent the robotic bronchoscopy procedure.</description>
          <population>54 patients underwent the robotic bronchoscopy procedure</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to R-EBUS Confirmation (Lesion Localization)</title>
        <description>Defined by the time the robotic bronchoscope is inserted into the oropharynx until the localization of the targeted lesion is confirmed by REBUS.</description>
        <time_frame>During the procedure, approximately 1 hour</time_frame>
        <population>Radial probe endobronchial ultrasound was available in 53/54 cases.</population>
        <group_list>
          <group group_id="O1">
            <title>Robotic Assisted Bronchoscopy</title>
            <description>Robotic assisted bronchoscopy procedures will be performed using the Monarch platform.&#xD;
Robotic assisted bronchoscopy: Robotic assisted bronchoscopy of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to R-EBUS Confirmation (Lesion Localization)</title>
          <description>Defined by the time the robotic bronchoscope is inserted into the oropharynx until the localization of the targeted lesion is confirmed by REBUS.</description>
          <population>Radial probe endobronchial ultrasound was available in 53/54 cases.</population>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="25" upper_limit="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Procedure Time</title>
        <description>Defined by the time the robotic bronchoscope is inserted into the oropharynx until the time a biopsy tool is removed.</description>
        <time_frame>During the procedure</time_frame>
        <population>54 patients underwent the robotic bronchoscopy procedure</population>
        <group_list>
          <group group_id="O1">
            <title>Robotic Assisted Bronchoscopy</title>
            <description>Robotic assisted bronchoscopy procedures will be performed using the Monarch platform.&#xD;
Robotic assisted bronchoscopy: Robotic assisted bronchoscopy of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Procedure Time</title>
          <description>Defined by the time the robotic bronchoscope is inserted into the oropharynx until the time a biopsy tool is removed.</description>
          <population>54 patients underwent the robotic bronchoscopy procedure</population>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51" lower_limit="25" upper_limit="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diagnostic Yield</title>
        <description>Determined from the results of the bronchoscopy.</description>
        <time_frame>Data was collected (as part of standard of care) through 1-year for calculation of diagnostic yield.</time_frame>
        <population>54 patients underwent the robotic bronchoscopy procedure</population>
        <group_list>
          <group group_id="O1">
            <title>Robotic Assisted Bronchoscopy</title>
            <description>Robotic assisted bronchoscopy procedures will be performed using the Monarch platform.&#xD;
Robotic assisted bronchoscopy: Robotic assisted bronchoscopy of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions.</description>
          </group>
        </group_list>
        <measure>
          <title>Diagnostic Yield</title>
          <description>Determined from the results of the bronchoscopy.</description>
          <population>54 patients underwent the robotic bronchoscopy procedure</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected from time of procedure through 84 hours post procedure.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Robotic Assisted Bronchoscopy</title>
          <description>Robotic assisted bronchoscopy procedures will be performed using the Monarch platform.&#xD;
Robotic assisted bronchoscopy: Robotic assisted bronchoscopy of peripheral airways in human subjects for the purpose of biopsying peripheral lung lesions.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Scott Rehage</name_or_title>
      <organization>Auris Health, Inc.</organization>
      <phone>9256832590</phone>
      <email>scott.rehage@aurishealth.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

